ArticleFrontiers in oncology2026
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study is to evaluate the ability of Methods: One-hundred and twenty-five patients with colorectal cancers and 57 with colorectal adenomas were retrospectively analyzed. Parameters assessed on Results: Colorectal carcinomas demonstrated significantly higher SUVmax (P = 0.003), SUVmean (P = 0.005), MTV (P < 0.001) and TLG (P< 0.001). The AUCs for differentiating colorectal carcinomas and adenomas were 0.657, 0.649, 0.979, and 0.987, for SUVmax, SUVmean, MTV, and TLG, respectively. The optimal cut-off value for MTV and TLG was 3.5 and 22.6, respectively, yielding a high sensitivity and specificity (96.5% and 92.5% for MTV, 96.5% and 95.5% for TLG). The optimal cut-off value for SUVmax and SUVmean was 8.8 and 4.4, respectively, yielding a sensitivity of 88.6% for SUVmax and 95.6% for SUVmean, and a low specificity of 42.5% for SUVmax, and 32.5% for SUVmean. Conclusions: Of the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.